Drugmakers will have to comply with a Minnesota law requiring them to provide free insulin to state residents who meet certain eligibility criteria, as they lack the ability to sue for an order blocking the law’s enforcement, a federal court in the state said.
The Pharmaceutical Research and Manufacturers of America—a nonprofit whose members include insulin makers
The plaintiffs argued the act’s provisions violated the Fifth Amendment’s takings clause because they would cause drugmakers to incur significant losses by ...
Learn more about Bloomberg Law or Log In to keep reading:
See Breaking News in Context
Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.
Already a subscriber?
Log in to keep reading or access research tools and resources.